ACTH-Secreting Pituitary Adenoma clinical trials
The registry lists 4 studies for ACTH-Secreting Pituitary Adenoma across 3 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-03-11.
Get an email when these change. Save the ACTH-Secreting Pituitary Adenoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Unity Health Toronto (1) · Hospices Civils de Lyon (1) · Seth Gordhandas Sunderdas Medical College (1) · Imperial College London (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
Who these studies take
Of the 1 ACTH-Secreting Pituitary Adenoma studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (100%) | 1 (100%) |
| 30 | 1 (100%) | 1 (100%) |
| 40 | 1 (100%) | 1 (100%) |
| 50 | 1 (100%) | 1 (100%) |
| 65 | 1 (100%) | 1 (100%) |
| 75 | 1 (100%) | 1 (100%) |
| 85 | 1 (100%) | 1 (100%) |
Across all 4 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 25% take children; 0% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. search them.
- Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.RecruitingNCT074636251 country
- Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma DetectionNot yet recruitingNCT06701838
- Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education ToolsStatus unknownNCT01775332Not applicable1 country
- Study of Cabergoline in Treatment of Corticotroph Pituitary TumorCompletedNCT00889525Phase 31 country